Medicare’s Drug Price Controls Could Actually Raise Prices In The Long Run
Lawmakers promised that letting Medicare set drug prices would save taxpayers more than $100 billion over a decade.
New research suggests the IRA may accomplish the opposite in the long run.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.forbes.com — the content belongs to Forbes.
